Sinoway Industrial Co., Ltd.

Celecoxib 169590-42-5 Celecoxib 169590-42-5

Celecoxib 169590-42-5
Related Products
  • NanoActive alpha lipoic acid (ALA) 1077-28-7

    1.Basic information of NanoActive alpha lipoic acidProduct Name: NanoActive alpha lipoic acid (ALA)Other Names: NanoActive THIOOCTIC ACIDAppearance: yellow, viscous and transparent liquidTest Method: ...

  • NanoActive Astaxanthin 472-61-7

    1.Basic information of NanoActive AstaxanthinProduct Name: NanoActive AstaxanthinOther Names: NanoActive AstaAppearance: reddish to dark red, viscous and transparent liquidTest Method: HPLCCAS NO.: 47...

  • NanoActive Curcumin 458-37-7

    1.Basic information of NanoActive CurcuminProduct Name: NanoActive CurcuminOther Names: NanoActive turmeric extractAppearance: yellow, viscous and transparent liquidTest Method: HPLCCAS NO.: 458-37-7S...

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.

  • Ezetimibe 163222-33-1
    Basic information of Ezetimibe :NameEzetimibeCAS :163222-33-1Molecular FormulaC24H21F2NO3Molecular Weight409.43Quality StandardIn house standard. 98%-102%Package SizeFor small quantity:Double plastic ... Ezetimibe 163222-33-1
  • Febantel 58306-30-2
    Basic information of FebantelNameFebantelAliasmethyl N-[N-[2-[(2-methoxyacetyl)amino]-4-phenylsulfanyl-phenyl]-N'-methoxycarbonyl-carbamimidoyl]carbamateCAS NO.58306-30-2Molecular Formula C20H22N4O6SM... Febantel 58306-30-2
  • Rabeprazole Sodium 117976-90-6
    Basic InformationProduct Name: Rabeprazole sodium Cas No.: 117976-90-6Molecular Formula: C18H20N3NaO3SMolecular Weight: 381.42Color: almost whiteDocuments: GMP, DMFUses of Rabeprazole sodium enteric... Rabeprazole Sodium 117976-90-6
  • Donepezil Hydrochloride 110119-84-1&120011-70-3
    Basic information of Donepezil hydrochlorideNameDonepezil hydrochloride AliasDonepezilHCLCAS NO.120011-70-3 /110119-84-1Molecular Formula C24H29NO3·HCLMolecular Weight 415.95Quality StandardGMP cert... Donepezil Hydrochloride 110119-84-1&120011-70-3

MORE_DETAIL Celecoxib 169590-42-5

Basic information of Celecoxib:

Name

Celecoxib

CAS NO.

169590-42-5

Molecular Formula

C17H14F3N3O2S

Molecular Weight

381.38

Grade Standard

Medicine grade  / 99% min / USP/ EP / GMP application / PMDA / DMF

Package Size

25kg/drum

Storage:

Keep in a well-closed container, protected from light and stored at a temperature of 2 to 8


Use of Celecoxib: 

Celecoxib is used to relieve the symptoms and signs of osteoarthritis, relieve the symptoms and signs of rheumatoid arthritis, and treat acute pain in adults.

The highest blood concentration was achieved approximately 3 hours after oral administration of a single dose of celecoxib. In the fasting state, when the dose of celecoxib is as high as 200mg twice daily, the highest blood concentration (Cmax) and the area under the curve (AUC) are roughly proportional to the dose; when the dose is increased, this proportional relationship Weaken (see food effects). At present, no studies have been conducted on absolute bioavailability. Steady-state plasma levels can be reached within 5 days after multiple doses.

COA of Celecoxib :


COA of Celecoxib

* Products under the patent are only for R&D use.
Leave a Message Email Us

We will contact you within 24 hours.

  • TEL:+86-0592-5853819
  • FAX:+86-0592-5854960
  • EMAIL: xie@china-sinoway.com
  • ADDRESS:Floor 16, Huicheng Business Center, No. 839, Xiahe Rd., Siming Dist. Xiamen, Fujian, China
//